Profit down at British pharma AstraZeneca in second quarter

Published by

There was a significant drop in profit year-on-year at British pharmaceutical firm AstraZeneca Plc in the second quarter. AstraZeneca reported on Friday that its second-quarter profit before tax was $247 million, down 68% from last year’s $764 million. Earnings per share declined 45% to $0.23 from $0.42 a year ago.Core earnings per share were $1.72, up 92% from last year. Total revenue grew 31% to $10.77 billion from last year’s $8.22 billion. Revenues grew 37% at constant currency rates. Further, the company declared interim dividend of $0.93 or 76.4 pence per ordinary share, reflecting the B…

Read More

Leave a Reply